
Tiratricol NEW
Price | $48 | $95 |
Package | 100mg | 500mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-29 |
Product Details
Product Name: Tiratricol | CAS No.: 51-24-1 |
Purity: 99.16% | Supply Ability: 10g |
Release date: 2025/04/29 |
Product Introduction
Bioactivity
Name | Tiratricol |
Description | Tiratricol (3,3',5-Triiodothyroacetic acid) is a metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome. |
In vivo | Research indicates that Tiratricol can reduce thyroid enlargement and mitigate atrophy caused by decreased use of corticosteroid hormones. Furthermore, Tiratricol is effective in treating thyroid hormone resistance syndrome and, in combination with thyroxine, can suppress the production of thyroid-stimulating hormone in patients with thyroid cancer. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 93 mg/mL (149.53 mM), Sonication is recommended. Ethanol : 93 mg/mL (149.53 mM), Sonication is recommended. |
Keywords | Tiratricol | Thyroidhormonereceptor(THR) | Thyroidhormonereceptor | Thyroid hormone receptor(THR) | Thyroid Hormone Receptor | Thyroid hormone receptor | Thyroid hormone | THR | Inhibitor | inhibit |
Inhibitors Related | Propylthiouracil | Azetirelin | Liothyronine | L-Thyroxine | L-Thyroxine sodium | Resmetirom | 2,2-BIS(2-HYDROXY-5-BIPHENYLYL)PROPANE | Carbimazole | Methimazole | Liothyronine sodium | 2-Thiouracil | PCO371 |
Related Compound Libraries | Nuclear Receptor Compound Library | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | Pediatric Drug Library | ReFRAME Related Library | Anti-Obesity Compound Library | Drug Repurposing Compound Library | NO PAINS Compound Library | Endocrinology-Hormone Compound Library | Bioactive Compounds Library Max | Drug Metabolite/Impurity Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1KG |
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
|
2020-10-14 | ||
$0.00/1g |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-08-13 | |
$1.00/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-14 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY